As of 2026-09-23, the Relative Valuation of Precigen Inc (PGEN) is (9.54) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.89 USD, the upside of Precigen Inc based on Relative Valuation is -221.0%.
The range of the Relative Valuation is (8.18) - (11.58) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.5x - 26.2x | 22.4x |
| Forward P/E multiples | 15.8x - 26.4x | 20.8x |
| Fair Price | (8.18) - (11.58) | (9.54) |
| Upside | -203.7% - -246.8% | -221.0% |
| Date | P/E |
| 2026-09-21 | -17.66 |
| 2026-09-18 | -17.59 |
| 2026-09-17 | -17.79 |
| 2026-09-16 | -16.81 |
| 2026-09-15 | -15.82 |
| 2026-09-14 | -15.49 |
| 2026-09-11 | -15.49 |
| 2026-09-10 | -15.10 |
| 2026-09-09 | -15.37 |
| 2026-09-08 | -15.53 |
| 2026-09-04 | -16.05 |
| 2026-09-03 | -16.14 |
| 2026-09-02 | -15.85 |
| 2026-09-01 | -15.51 |
| 2026-08-31 | -15.67 |
| 2026-08-28 | -15.71 |
| 2026-08-27 | -16.25 |
| 2026-08-26 | -16.77 |
| 2026-08-25 | -16.46 |
| 2026-08-24 | -16.21 |
| 2026-08-21 | -16.28 |
| 2026-08-20 | -16.82 |
| 2026-08-19 | -16.19 |
| 2026-08-18 | -15.26 |
| 2026-08-17 | -14.81 |
| 2026-08-14 | -13.79 |
| 2026-08-13 | -14.67 |
| 2026-08-12 | -15.49 |
| 2026-08-11 | -15.51 |
| 2026-08-10 | -15.82 |
| 2026-08-07 | -16.34 |
| 2026-08-06 | -15.62 |
| 2026-08-05 | -15.58 |
| 2026-08-04 | -14.76 |
| 2026-08-03 | -14.94 |
| 2026-07-31 | -14.17 |
| 2026-07-30 | -13.43 |
| 2026-07-29 | -12.32 |
| 2026-07-28 | -12.50 |
| 2026-07-27 | -12.25 |
| 2026-07-24 | -12.21 |
| 2026-07-23 | -12.52 |
| 2026-07-22 | -12.03 |
| 2026-07-21 | -12.41 |
| 2026-07-20 | -11.46 |
| 2026-07-17 | -11.19 |
| 2026-07-16 | -11.19 |
| 2026-07-15 | -11.57 |
| 2026-07-14 | -11.57 |
| 2026-07-13 | -11.69 |